3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
3
Phase NA
2
Phase 4
1
Phase 3
1
Phase 2
1
Phase 1
1
Status
Completed
4
Terminated
3
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
173
Leukemia, Myeloid, Acute
152
Breast Neoplasms
146
Neoplasms
143
Neoplasm Metastasis
142
Colorectal Neoplasms
137
Recurrence
105
Ovarian Neoplasms
101
Pancreatic Neoplasms
83
Advanced Solid Tumor
82
Lung Neoplasms
81
Multiple Myeloma
77
Prostatic Neoplasms
75
Advanced Solid Tumors
74
Stomach Neoplasms
73
Squamous Cell Carcinoma of Head and Neck
72
Carcinoma, Hepatocellular
68
Glioblastoma
65
Melanoma
64
Lymphoma, Non-Hodgkin
64
Triple Negative Breast Neoplasms
59
Lymphoma, B-Cell
55
Endometrial Neoplasms
54
Myelodysplastic Syndromes
53
Precursor Cell Lymphoblastic Leukemia-Lymphoma
52
Lymphoma
52
Glioma
51
Brain Neoplasms
46
Carcinoma, Renal Cell
44
Hematologic Neoplasms
43
Interventions
darolutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Recruiting
×
Prostatic Diseases
×
Clear all
NCT07103018
2026-03-23
STRIKE-001
K36 Therapeutics, Inc.
Phase 1
Recruiting
144 enrolled